Neovascularization is necessary for formation of the corpus luteum (CL) and includes angiogenesis and vasculogenesis. Vasculogenesis is the formation of new blood vessels by bone marrow-derived endothelial progenitor cells. Here we investigated whether vasculogenesis occurs in neovascularization during CL formation. Mice transplanted with bone marrow from transgenic mice expressing green fluorescent protein (GFP) were injected with equine chorionic gonadotropin and human chorionic gonadotropin (hCG) to induce ovulation and subsequent CL formation. Immunohistochemistry was performed on the ovaries obtained before hCG injection and at 6, 12, and 24 h after hCG injection using antibodies for CD34 or CD31 (an endothelial cell marker), platelet-derived growth factor receptor beta (PDGFR-beta, a pericyte marker), F4/80 (a macrophage marker), and GFP (a bone marrow-derived cell marker). Cells immunostained for CD34, PDGFR-beta, F4/80, and GFP were present in the theca cell layer of the preovulatory follicle before hCG injection. Each of these cell types invaded the granulosa cell layer after hCG injection, and a number of them were observed in the CL 24 h after hCG injection. Fluorescence-based immunohistochemistry or double immunohistochemical staining revealed that a few CD34/CD31-positive cells and PDGFR-betapositive cells were also positive for GFP in the preovulatory follicle and CL, and that many of the GFP-positive cells recruited to the CL during CL formation were F4/80-positive macrophages. In conclusion, bone marrow-derived vascular progenitor cells and macrophages contribute to neovascularization during CL formation.
INTRODUCTION
Angiogenesis is required for the formation and development of the corpus luteum (CL) [1, 2] . After the surge of luteinizing hormone (LH) during ovulation, vascular endothelial cells of the theca cell layer proliferate and invade the avascular granulosa cell layer, which is the first step of CL formation. Thereafter, blood vessels are rapidly formed in the CL, and the CL becomes one of the most highly vascularized organs in the body. Formation of this vascular network is required so that luteal cells can continue producing progesterone during pregnancy.
Neovascularization includes angiogenesis and vasculogenesis. Angiogenesis is the development of blood vessels through the proliferation of vascular endothelial cells and the sprouting of microvessels from preexisting blood vessels. Vasculogenesis refers to new blood vessel formation by bone marrow-derived endothelial progenitor cells and is a characteristic of embryogenesis [3] . However, vasculogenesis has been reported to play a role in neovascularization in a variety of organs and even in adults [4, 5] . This raises the possibility that vasculogenesis also contributes to neovascularization during CL formation after the ovulatory LH surge.
For successful pregnancy, luteal cells need to be supplied with large amounts of cholesterol to maintain progesterone production. This requires stabilization of blood vessels in addition to high vascularization in the CL because mature blood vessels are critical for maintaining blood flow [6] [7] [8] . Blood vessel stabilization is regulated by pericytes, which support the interaction between endothelial cells [9] . Although the number of pericytes during CL development changes in humans [9] , there are conflicting reports about whether pericytes exist in the rodent CL, and it is unclear where pericytes come from if they are present in the CL in mice [10, 11] . Therefore, it is interesting to investigate the possible mechanism underlying the recruitment of pericytes. One possibility is that progenitor cells of pericytes come from the bone marrow and play a role in the neovascularization during CL formation.
Recent studies suggest that macrophages contribute to neovascularization in various organs. Macrophages not only have a role as structural components of blood vessels but also enhance angiogenesis through the release of various angiogenic factors [12, 13] . Furthermore, macrophage ablation was recently been shown to disrupt ovarian vascular integrity in mice, suggesting that macrophages play a functional role in supporting CL vasculature [14] . Interestingly, the number of macrophages was found to increase in follicles undergoing luteinization after the ovulatory LH surge [15] . Therefore, it is likely that macrophages also play a role in the neovascularization that occurs during CL formation.
In order to investigate whether bone marrow-derived progenitor cells of vascular endothelial cells or pericytes and macrophages contribute to neovascularization during CL formation, we examined the changes in these cell types during CL formation using a bone marrow transplantation (BMT) mouse model.
MATERIALS AND METHODS

Animals
C57BL/6NCrSlc mice were purchased from Japan SLC, Inc. Green fluorescence protein (GFP)-expressing mice (C57BL/6-Tg [CAG-EGFP]) were kindly supplied by Dr. Masaru Okabe (Osaka University, Osaka, Japan). The mice were housed at 248C under controlled conditions (lights on from 0500 to 1900 h) under specific pathogen-free conditions and were fed standard chow. All the experimental protocols were reviewed by the Ethics Committee for Animal Experimentation of Yamaguchi University Graduate School of Medicine and carried out according to the guidelines for Animal Experimentation of the Yamaguchi University Graduate School of Medicine and under the Law and Notification requirements of the Japanese Government.
BMT Model
Bone marrow cells were obtained by flushing the tibias and the femurs of 6-wk-old donor GFP-transgenic mice. Bone marrow mononuclear cells were isolated by density centrifugation over Histopaque-1083 (Sigma-Aldrich, Co.). Recipient C57BL/6 mice (4 wk) were lethally irradiated by placing each mouse in a plastic thin-walled box. The animals received whole body irradiation of 9.0 Gy from an x-ray machine (MBR-1520; Hitachi Medical Co.) and then received donor 1 3 10 7 bone marrow mononuclear cells intravenously via the tail vein. To determine whether BMT had succeeded, the percentage of the cells expressing GFP in the bone marrow and peripheral blood was measured by flow cytometry 4 wk after BMT [16, 17] . Blood and bone marrow were taken from the right ventricle and the femurs, respectively, under diethylether anesthesia. The red blood cells and bone marrow cells were hemolyzed with Immunoprep Reagent System (Beckman Coulter, Inc.). Cells were suspended in 2% bovine serum albumin/PBS at a concentration of 1 3 10 6 cells/ml followed by incubation with propidium iodide (Sigma-Aldrich). Flow cytometry was performed using an FC500 cytometer (Beckman Coulter). Almost all (97%) of the bone marrow cells and 81% of the peripheral blood cells were GFP positive in the BMT model (Fig. 1) . Four wk after BMT, BMT mice were used for the experiment described below.
The BMT mice had ovaries damaged by irradiation. The size of the ovary of the BMT mice (mean weights: 2.1 6 1.0 g) was smaller than that of wild-type mice (4.7 6 1.4 g). The number of the preovulatory follicle in the BMT mice treated with follicle-stimulating hormones was from two to four per ovary at autopsies, suggesting a poor response of the BMT mice to gonadotropins.
Experimental Procedures
BMT model mice (8 wk) and C57BL/6 wild-type mice (7 wk) were pretreated with subcutaneous injection of gonadotropin-releasing hormone analog (GnRHa) depot (50 lg/mouse) to suppress endogenous gonadotropin production according to a previous report [18] . GnRHa (leuprolide acetate, a water-soluble dried peptide) was kindly provided by Takeda Chemical Industries, Ltd. To induce ovulation and the subsequent CL formation, the animals received 10 international units (IU)/mouse equine chorionic gonadotropin (eCG) (Merck KGaA) intraperitoneally after GnRHa injection, followed by an intraperitoneal injection of 10 IU/mouse human chorionic gonadotropin (hCG) (C1063; Sigma-Aldrich) 48 h later. The ovary was removed before hCG injection and at 6, 12, and 24 h after hCG injection. When the newly formed CL and previously formed CL induced by GnRHa treatment were observed in the ovary, they were easily distinguished by appearance. In short, the newly formed CL was larger than the previously formed CL, and the newly formed CL appeared red whereas the previously formed CL appeared whitish.
Immunohistochemistry
For fluorescence-based immunohistochemistry, mice were anesthetized by inhalation of Forane (isoflurane; Abbott Laboratories) and then transcardially perfused with 4% paraformaldehyde in phosphate buffer (pH 7.4). The ovaries were removed, immersed in phosphate buffer containing 30% sucrose, and embedded in optimal-cutting temperature compound (Sakura Finetek Co.). The ovarian tissue sections (10 lm) were prepared on a cryostat (CM 1850; Leica Microsystems Inc.). The fluorescence-based immunohistochemistry was performed as described previously [19] . The primary antibodies used in this study were rat anti-mouse CD31, an endothelial cell marker [20] . Anti-goat immunoglobulin G (IgG)-Alexa594 (1:100) and anti-goat IgG-488 (1:500; Invitrogen Corp.) were used as the secondary antibodies. After counterstaining with 4 0 ,6-diamidino-2-phenylindole (DAPI, 0.5 lm/ml; Invitrogen), the sections were covered with Fluoromount (Diagnostic BioSystems) and observed using a confocal laser microscope (LSM510 META; Carl Zeiss). For negative controls, sections were incubated with normal goat serum instead of primary antibodies.
For enzyme-based immunohistochemistry, ovaries were embedded in paraffin. Paraffin-embedded ovaries were sectioned at 4 lm, and the sections were deparaffinized in xylene and rehydrated in a graded series of ethanol. The enzyme-based immunohistochemistry was performed as described previously [6] . The primary antibodies used in the enzyme-based immunohistochemistry were rat anti-mouse CD34, an endothelial cell marker (HM1015, dilution 1:50; Hycult Biotechnology), rabbit anti-GFP (ab290, dilution 1:2000; Abcam plc.), and rabbit anti-PDGFR-b (dilution: 1/1000). When CD34 antibodies were used, the tissues were microwaved at 958C for 20 min in 0.01 M citrate containing 0.1% Tween 20 epitope retrieval buffer (pH 6.0). The sections were subsequently visualized using the avidin-biotinylated peroxidase complex system (Vector Laboratories, Inc.) with 3,3 0 -diaminobenzidine tetrahydrochloride (3, 3 0 -DAB) and were counterstained with hematoxylin. For negative controls, sections were incubated with normal goat serum instead of primary antibodies.
Double immunohistochemical staining for GFP and CD34 was performed as described previously with some modifications [21] . Briefly, deparaffinized sections were incubated with the rabbit anti-GFP antibody (dilution 1:2000), and subsequently visualized with 3,3 0 -DAB. After the sections were placed in boiling citric acid buffer (pH 6.0) for 20 min, the slides were incubated with the rat anti-mouse CD34 antibody (dilution 1:50), and visualized by True Blue (KPL, Inc.). Methyl green was used for counterstaining the nuclei. For double immunostaining for GFP and PDGFR-b, sections were incubated with the rabbit anti-PDGFR-b antibody (dilution 1:200), visualized with DAB solution, reacted with anti-GFP antibody (dilution 1:5000), and then visualized by Vector Blue (Vector Laboratories, Inc.). No counterstaining was performed in this double immunostaining. For immunohistochemistry, 6 to 12 ovaries obtained from three to six mice were used in each experimental time point, and immunostaining was evaluated on three to four tissue sections in each ovary. KIZUKA ET AL.
RESULTS
We first examined the time course of neovascularization during CL formation in the mouse models. Figure 2 shows immunohistochemistry for CD34, a vascular endothelial cell marker. CD34-positive blood vessels were present in the theca cell layer of the preovulatory follicle before hCG injection (0 h), then vascular endothelial cells invaded the granulosa cell layer after hCG injection, and the CL was formed with high vascularity 24 h after hCG injection in the wild-type mice treated with eCG-hCG ( Fig. 2A) or GnRHaþeCG-hCG (Fig.  2B ). This finding is consistent with a well-known pattern of neovascularization during CL formation in mice. The BMT model showed a similar time course pattern of neovascularization during CL formation, and corpora lutea were normally formed 24 h after hCG injection. Therefore, we decided to use the BMT mice as an animal model to see neovascularization during CL formation although the BMT model mice have ovaries damaged by irradiation. However, the BMT model showed a different finding in that CD34-positive endothelial cells were present in the granulosa cell layer of the preovulatory follicle before hCG injection (Fig. 2C) , which may be due to damage of the basement membrane in the BMT model. Figure 3A shows the change in GFP-positive cells (bone marrow-derived cells) during CL formation in the BMT model. GFP-positive cells were present in the theca cell layer of the preovulatory follicle before hCG injection (0 h) and invaded the granulosa cell layer after hCG injection. There were a number of GFP-positive cells in the CL 24 h after hCG injection. To determine whether any GFP-positive cells are also CD34-positive, double immunostaining for CD34 and GFP was performed in the BMT model. Double immunostaining (Fig. 3B) showed that a few double-positive cells for CD34 and GFP were present in the theca cell layer of the preovulatory follicle before hCG injection, in the granulosa cell layer undergoing luteinization, and in the CL 24 h after hCG FIG. 2. Time course of neovascularization during CL formation after ovulatory hCG stimulation. Time course of neovascularization during CL formation was investigated in the mouse models in this study using immunohistochemistry for CD34, a vascular endothelial cell marker. The ovary was removed before hCG injection (0 h) and 6, 12, and 24 h after hCG injection in the mouse models treated with eCG-hCG. A) Wild-type mice (3 wk) treated with eCG-hCG. B) Wild-type mice (7 wk) treated with eCG-hCG after pretreatment with GnRHa. C) BMT model (8 wk) treated with eCG-hCG after pretreatment with GnRHa. Six to twelve ovaries obtained from three to six mice were used in each experimental time point, and immunostaining was evaluated on three to four tissue sections in each ovary. The second row of the figures shows higher magnification of the detailed immunohistochemical finding. T, theca cell layer; G, granulosa cell layer. Bars ¼ 50 lm.
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injection. Fluorescence-based immunohistochemistry also showed the presence of CD31-positive vascular endothelial cells that are identical to GFP-positive cells in the theca cell layer of the preovulatory follicle before hCG injection and in the CL 24 h after hCG injection (Fig. 3C) . Although the number of double-positive cells for CD34/CD31 and GFP was so small that they were not quantified, the proportion of GFPpositive cells in CD34/CD31-positive cells was estimated to be less than 5%. However, these findings indicate the presence of bone marrow-derived vascular endothelial cells in the preovulatory follicle and in the CL, suggesting that bone marrowderived endothelial progenitor cells contribute to neovascularization during CL formation. Figure 4A shows the time course of pericytes during CL formation in the BMT model. Cells positive for PDGFR-b (a marker of pericytes) were present in the theca cell layer before hCG injection (0 h) and invaded the granulosa cell layer after hCG injection. Many PDGFR-b-positive cells were observed in the CL 24 h after hCG injection. To determine whether any PDGFR-b-positive cells are also GFP-positive, double immunostaining for PDGFR-b and GFP and fluorescence-based immunohistochemistry were performed on the BMT model mice. Double immunostaining (Fig. 4B) showed that doublepositive cells for PDGFR-b and GFP were present in the CL 24 h after hCG injection. Fluorescence-based immunohistochemistry also showed the presence of cells that were positive for both PDGFR-b and GFP in the theca cell layer of the preovulatory follicle before hCG injection and in the CL 24 h after hCG injection (Fig. 4C) . These findings suggest that bone marrow-derived pericytes are present in the preovulatory follicle and in the CL. Although the number of double-positive cells for PDGFR-b and GFP was so small that they were not quantified, the proportion of GFP-positive cells in PDGFR-bpositive cells was estimated to be less than 5%. Figure 5A shows the time course of macrophages during CL formation in the BMT model. Cells positive for F4/80 (a macrophage marker) were present in the theca cell layer before hCG injection (0 h) and increased in number during CL formation after hCG injection. Many F4/80-positive cells were observed in the CL 24 h after hCG injection. F4/80-positive cells were observed in the granulosa cell layer of the preovulatory follicle before hCG injection (Fig. 5A) , which may be due to ovarian damage by irradiation in the BMT model. Fluorescence-based immunohistochemistry also showed the presence of F4/80-positive macrophages that are identical to GFP-positive cells in the preovulatory follicle before hCG injection and in the CL 24 h after hCG injection (Fig. 5B) . Many of GFP-positive cells were F4/80-positive macrophages. Macrophages surrounding the blood vessel were observed in the CL (Fig. 5B, 24 h ). These findings suggest that a number of macrophages are recruited to the ovary from bone marrow during CL formation.
DISCUSSION
The present study using the BMT model showed the presence of bone marrow-derived endothelial progenitor cells that differentiate into vascular endothelial cells in the follicle undergoing luteinization during CL formation after ovulatory hCG stimulation. This suggests that vasculogenesis, at least in part, contributes to neovascularization during CL formation. In fact, vasculogenesis has been reported to play a role in BONE MARROW-DERIVED CELLS AND CL VASCULATURE neovascularization during uterine endometrial growth [16] , wound healing [22, 23] and tumor growth [24] in a variety of organs.
One may wonder whether our result saw vasculogenesis because CD34/CD31 and GFP-double positive cells were already present in the granulosa cell layer before HCG injection in the BMT model. To avoid the irradiation damage and to examine whether circulating vascular progenitor cells actually contribute to neovascularization during CL formation, we used a parabiosis model, in which a wild-type mouse and a GFP-transgenic mouse are conjoined subcutaneously and share a common circulation, under the approval from the Ethics Committee for Animal Experimentation of Yamaguchi University Graduate School of Medicine. The parabiosis model showed that CD31/CD34 and GFP-positive cells were not observed in the granulosa cell layer before hCG injection and were observed in the CL after hCG injection (data not shown). This result may support the conclusion that vasculogenesis occurs during CL formation.
Our result showed that the number of the bone marrowderived endothelial progenitor cells incorporated into the blood vessel by the mechanism of vasculogenesis was low, which is consistent with the result observed in the mouse uterine endometrium [16] . The finding suggests that the increase in vascular endothelial cells during CL formation results from the proliferation of preexisting endothelial cells in the follicle, which is also shown in the primate corpus luteum [25] . However, it is interesting to note that bone marrow-derived endothelial progenitor cells indirectly contribute to neovascularization by stimulating proliferation or invasion of preexisting vascular endothelial cells [26] . Much attention has been given to the involvement of paracrine signals secreted by endothelial progenitor cells in neovascularization because endothelial progenitor cells produce various angiogenic factors, growth factors, and cytokines such as vascular endothelial growth factor (VEGF), pigment epithelium-derived factor, insulin-like growth factor-1, stromal cell-derived factor-1, hepatocyte growth factor, and granulocyte-macrophage colony-stimulating factor (G-CSF) [22, 26] . The main role of endothelial progenitor cells in neovascularization has been currently considered to stimulate proliferation or invasion of preexisting vascular endothelial cells [22, 26] rather than directly constitute blood vessels by the mechanism of vasculogenesis [4, 5] .
It is unclear how bone marrow-derived endothelial progenitor cells are recruited to the follicle undergoing luteinization. We speculate that endothelial progenitor cells are mobilized into the circulation from bone marrow in response to high estrogen levels around the ovulatory period, and then circulating endothelial progenitor cells are recruited into the follicle undergoing luteinization because of high local levels of VEGF or cytokines. VEGF or cytokines such as G-CSF are locally produced in the follicle during the ovulatory process after the LH surge [1, 2] . In fact, estrogen mobilizes circulating endothelial progenitor cells from bone marrow, resulting in their incorporation into sites of neovascularization in the endometrium [16, 27, 28] and in the heart in mice [29] , and VEGF or G-CSF acts to mobilize circulating endothelial progenitor cells [22, 30] .
The presence of pericytes in the rodent CL is still controversial because pericytes in the rodent CL are not immunoreactive for alpha smooth muscle actin, which is one of the markers for pericytes [10, 11, 13] . Because selective inhibition of the PDGFR-b pathway to inhibit pericyte recruitment disrupted the integrity of the CL vasculature in mice [10] , we used an antibody for PDGFR-b to detect pericytes in the mouse CL in this study. Our result clearly showed the change in the pericyte distribution during CL formation after ovulatory hCG stimulation in mice. Pericytes were present in the theca cell layer before hCG injection and increased in number during CL formation after hCG injection. This change was very similar to the change in vascular endothelial cells. These findings on endothelial cells and pericytes are consistent with previous reports that pericytes are often present during the initial stages of neovascularization [13, 31] . Pericytes may contribute to blood vessel stabilization concomitantly with neovascularization during CL formation.
The mechanism underlying the recruitment of pericytes has been unclear. Our result shows that pericytes in the CL are at least partly derived from the bone marrow. However, the number of bone marrow-derived pericyte was small in the CL, suggesting that the increase in number of pericytes in the CL results from the proliferation of the preexisting pericytes in the follicle. In fact, pericytes are recruited and proliferate by the stimulation of the endothelial cells producing PDGF [20] . Further studies are needed to clarify the mechanism of pericyte recruitment.
Macrophages were present in the theca cell layer before hCG injection and increased in number during CL formation after ovulatory hCG stimulation, in good agreement with previous reports [15, 32] . Our result also shows that many of the bone marrow-derived cells recruited to the CL during CL formation were macrophages. Macrophages not only act as structural components of blood vessels, but also contribute to angiogenesis by producing various angiogenic factors including VEGF and basic fibroblast growth factor [12, 14] . Furthermore, recent evidence has shown that macrophage ablation disrupted ovarian vascular integrity and in extensive hemorrhage in the mouse CL, suggesting that macrophages have a role in maintaining blood vessel integrity in the CL [14] . Taken together, these results suggest that macrophages contribute to stable vascular network formation during CL formation.
Physiological neovascularization is restricted to the female reproductive system in which it occurs cyclically in the ovary and uterus. The present study showed that bone marrowderived vascular progenitor cells and macrophages contribute to neovascularization during CL formation. Furthermore, there appears to be collaboration among vascular endothelial cells, pericytes, and macrophages to complete neovascularization during CL formation. Analysis of neovascularization in the CL would provide useful information to the field of not only reproductive biology but also regenerative medicine, therapeutic neovascularization, and tissue engineering.
